BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6601330)

  • 1. [Changes in the lymphoid tissue of the axillary lymph nodes and the T-lymphocyte count of the blood of breast cancer patients].
    Lavnikova GA; Ivinskaia NV; Eremina OF
    Vopr Onkol; 1983; 29(2):43-6. PubMed ID: 6601330
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cellular reactions in tumor stroma and reactive changes in regional lymph nodes in breast cancer].
    Fedin IuV; Ermilova VD
    Vopr Onkol; 1984; 30(11):38-44. PubMed ID: 6334934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of mast cells in the axillary lymph nodes of breast cancer patients.
    Naik R; Baliga P; Bansal R; Pai M
    J Indian Med Assoc; 1997 Dec; 95(12):606-7. PubMed ID: 9586403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
    Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
    Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commentary on Barranger et al., Contralateral axillary lymph node drainage in breast cancer: a case report: unusual lymph drainage pathways in patients with breast cancer.
    Nieweg OE; van Rijk MC; Tanis PJ; Estourgie SH
    J Surg Oncol; 2004 Aug; 87(2):105-6. PubMed ID: 15282705
    [No Abstract]   [Full Text] [Related]  

  • 6. The impact of axillary lymph nodes removed in staging of node-positive breast carcinoma.
    Kuru B; Bozgul M
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1328-34. PubMed ID: 16997505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical management of the axilla: do intramammary nodes matter?
    Pugliese MS; Stempel MM; Cody HS; Morrow M; Gemignani ML
    Am J Surg; 2009 Oct; 198(4):532-7. PubMed ID: 19800463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histoenzymological and ultrastructural changes of axillary lymph nodes with breast cancer metastases.
    Bârsu M; Cotuţiu G; Dobrescu G; Carasevici E; Stoica L
    Morphol Embryol (Bucur); 1982; 28(4):299-302. PubMed ID: 6218399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axillary biopsy compared with dissection in the staging of lymph nodes in operable breast cancer. A randomised trial.
    Christensen SB; Jansson C
    Eur J Surg; 1993 Mar; 159(3):159-62. PubMed ID: 8102890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Very slight chance of other metastases in axillary nodes of breast cancer patients with a small sentinel node metastasis without extranodal tumor growth].
    van der Loo EM; Hop WC; Tervoort MA; de Graaf PW
    Ned Tijdschr Geneeskd; 2004 May; 148(19):938-43. PubMed ID: 15160561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J; Polgár C; Péley G; Németh G
    Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of axillary recurrence after axillary lymph node dissection for invasive breast cancer.
    Voogd AC; de Boer R; van der Sangen MJ; Roumen RM; Rutten HJ; Coebergh JW
    Eur J Surg Oncol; 2001 Apr; 27(3):250-5. PubMed ID: 11373100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Regional lymph nodes and mortality in breast cancer].
    Spirina NV; Ivinskaia NV
    Sov Med; 1989; (4):123. PubMed ID: 2788307
    [No Abstract]   [Full Text] [Related]  

  • 15. Contribution of minute axillary lymph nodes to accurate staging for patients with breast cancer.
    Jiang J; He QQ; Yang XH; Liang Y; Fan LJ; Zhang Y; Guo MQ
    Chin Med J (Engl); 2007 Oct; 120(20):1762-5. PubMed ID: 18028767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?
    Specht MC; Fey JV; Borgen PI; Cody HS
    J Am Coll Surg; 2005 Jan; 200(1):10-4. PubMed ID: 15631914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging for axillary staging in patients with breast cancer.
    Mortellaro VE; Marshall J; Singer L; Hochwald SN; Chang M; Copeland EM; Grobmyer SR
    J Magn Reson Imaging; 2009 Aug; 30(2):309-12. PubMed ID: 19466713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and importance of lymphocyte subpopulations in the regional lymph nodes of breast cancer patients.
    Khuri N; Jothy SP; Shibata HR
    Can J Surg; 1989 Jan; 32(1):23-6. PubMed ID: 2463069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variations in axillary staging: much ado about nothing?
    King TA
    Ann Surg Oncol; 2009 Mar; 16(3):549-51. PubMed ID: 19093154
    [No Abstract]   [Full Text] [Related]  

  • 20. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
    Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
    J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.